Clonal evolution of AML on novel FMS-like tyrosine kinase-3 (FLT3) inhibitor therapy with evolving actionable targets.
| Image |  |
|---|---|
| Description | scientific article |
| Author/s |
author: Mark R Litzow Pashtoon Murtaza Kasi |
| Publication date | January 12, 2016 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |